Literature DB >> 24327084

Thrombocytopenia in children with vivax malaria: a study from north India.

Chandra Mohan Kumar1, Shweta Singh, Rajnish Garg.   

Abstract

OBJECTIVES: To study incidence, severity and clinical significance of thrombocytopenia and to study recovery pattern of platelet counts in children with vivax malaria.
METHODS: This was a retrospective hospital based descriptive case series. Cases of confirmed vivax malaria were studied and their Total Platelet Counts (TPC) evaluated daily till recovery and again after 1 wk on follow up visit.
RESULTS: In this study out of 39 children of confirmed vivax malaria 22 had thrombocytopenia, having mean platelet count 48 × 10(9)/L on admission which showed a very quick recovery on treatment and by day 3 of treatment it rose to 126.5 × 10(9)/L without platelet transfusion. In untreated cases the lowest platelet counts was observed on day 5-6 and on treatment, platelet counts returned to normal without any platelet transfusion by 9th day. Even among children there are variations in different age groups and younger ones show more quicker recovery than older peers.
CONCLUSIONS: Vivax malaria is associated with transient thrombocytopenia which does not lead to significant bleeding in children.

Entities:  

Mesh:

Year:  2013        PMID: 24327084     DOI: 10.1007/s12098-013-1277-3

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  Profound thrombocytopenia in Plasmodium vivax malaria.

Authors:  A Kakar; S Bhoi; V Prakash; S Kakar
Journal:  Diagn Microbiol Infect Dis       Date:  1999-11       Impact factor: 2.803

2.  Thrombocytopenia in Plasmodium falciparum, Plasmodium vivax and mixed infection malaria: a study from Bikaner (Northwestern India).

Authors:  Dhanpat Kumar Kochar; Ashis Das; Abhishek Kochar; Sheetal Middha; Jyoti Acharya; Gajanand Singh Tanwar; Anjana Gupta; Deepak Pakalapati; Shilpi Garg; Vishal Saxena; Amit Kumar Subudhi; P A Boopathi; Parmendra Sirohi; Sanjay Kumar Kochar
Journal:  Platelets       Date:  2010-11-04       Impact factor: 3.862

3.  Thrombocytopenia in childhood malaria with special reference to P. vivax monoinfection: A study from Bikaner (Northwestern India).

Authors:  Gajanand Singh Tanwar; Punam Chand Khatri; Chandra Kumar Chahar; Ghanshyam Singh Sengar; Abhishek Kochar; Gayatri Tanwar; Shaifali Chahar; Nimish Khatri; Sheetal Middha; Jyoti Acharya; Sanjay Kumar Kochar; Deepak Pakalapati; Shilpi Garg; Ashis Das; Dhanpat Kumar Kochar
Journal:  Platelets       Date:  2011-08-24       Impact factor: 3.862

4.  Thrombocytopenia and other hematological complications in children with malaria.

Authors:  B R Santhanakrishnan; V Pushpa
Journal:  Indian J Pediatr       Date:  1985 May-Jun       Impact factor: 1.967

Review 5.  Thrombocytopenia--an indicator of acute vivax malaria.

Authors:  Aarti Kumar
Journal:  Indian J Pathol Microbiol       Date:  2006-10       Impact factor: 0.740

6.  Thrombocytopenia in malaria--correlation with type and severity of malaria.

Authors:  U M Jadhav; V S Patkar; N N Kadam
Journal:  J Assoc Physicians India       Date:  2004-08

7.  Anemia and thrombocytopenia in children with Plasmodium vivax malaria.

Authors:  Alfonso J Rodríguez-Morales; Elia Sánchez; Miguel Vargas; Carmelina Piccolo; Rosa Colina; Melissa Arria
Journal:  J Trop Pediatr       Date:  2005-06-24       Impact factor: 1.165

8.  Thrombocytopenia in malaria.

Authors:  S Looareesuwan; J G Davis; D L Allen; S H Lee; D Bunnag; N J White
Journal:  Southeast Asian J Trop Med Public Health       Date:  1992-03       Impact factor: 0.267

9.  Plasmodium vivax malaria presenting with severe thrombocytopenia, cerebral complications and hydrocephalus.

Authors:  Rekha Harish; Sanjeev Gupta
Journal:  Indian J Pediatr       Date:  2009-04-23       Impact factor: 1.967

10.  Plasmodium vivax malaria presenting with severe thrombocytopenia.

Authors:  Ravinder Pal Singh Makkar; Surabhi Mukhopadhyay; Amitabh Monga; Amitabh Monga; Ajay Kr Gupta
Journal:  Braz J Infect Dis       Date:  2002-10       Impact factor: 1.949

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.